Depressive disorder Mental and Behavioural Disorders Depressive episode
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who attend non-psychiatric clinics 2. Patients with Major Depressive Disorder (MDD), defined as a positive screen using the Patient Health Questionnaire (PHQ-9), confirmed with the Schedules of Clinical Assessment in Neuropsychiatry (SCAN) interview 3. Men or women aged 18 or older 4. Able to participate in a clinical diagnostic interview in either Mandarin or Fukienese dialects 5. Individuals who are willing to be followed up concerning their depression symptoms 6. Individuals who have completed a written consent form
Exclusion criteria
Exclusion criteria: 1. Women who are pregnant, breast-feeding or planning pregnancy within the next year 2. Patients with serious suicidal risk 3. Patients with unstable medical illnesses 4. Clinical or laboratory evidence of hypothyroidism 5. Patients with comorbid severe mental disorders including: 5.1. Organic mental disorders 5.2. Alcohol or substance abuse disorders active within the last year 5.3. Schizophrenia 5.4. Delusional disorder 5.5. Psychotic disorders not elsewhere classified 5.6. Bipolar disorder 5.7. Mood congruent or mood incongruent psychotic features 6. Patients with history of treatment by a psychiatrist in the past 4 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of adherence to treatment initiation, assessed by blind assessors at baseline and every four weeks from week 2 until week 26 or end point. | — |
Secondary
| Measure | Time frame |
|---|---|
| The following will be assessed by blind assessors at baseline and every four weeks from week 2 until week 26 or end point: 1. Rate of adherence to medication treatment 2. Rate of treatment completers 3. Rate of responders 4. Overall life satisfaction | — |
Countries
Taiwan